BioMed Research International / 2015 / Article / Tab 1 / Clinical Study
Effects of Surgical and Dietary Weight Loss Therapy for Obesity on Gut Microbiota Composition and Nutrient Absorption Table 1 Anthropometric and clinical parameters in the dietary (VLCD) and sleeve gastrectomy (LSG) intervention group before (month 0) intervention and after 3 and 6 months.
VLCD LSG Month 0 Month 3 Month 6 P * trendMonth 0 Month 3 Month 6 P * trendWeight [kg] 121.1 ± 4.9 100.4 ± 4.5 91.3 ± 3.9 0.0014 ** 127.5 ± 1.2 107.0 ± 2.4 97.1 ± 3.0 <0.0001 *** BMI [kg/m2 ] 40.2 ± 1.0 33.2 ± 1.0 30.3 ± 0.6 <0.0001 *** 45.8 ± 0.9 38.4 ± 1.2 35.0 ± 1.3 <0.0001 *** Waist [cm] 114.7 ± 5.2 104.8 ± 1.9 99.3 ± 1.7 0.0212 * 138.3 ± 3.6 122.0 ± 4.7 112.0 ± 4.2 0.0027 ** Weight loss [kg] 20.7 ± 0.4 29.8 ± 1.0 <0.0001 *** 20.5 ± 1.2 30.4 ± 1.8 0.0017 ** RWL [%] 17.2 ± 0.8 24.6 ± 0.8 0.0002 *** 16.1 ± 1.1 23.9 ± 1.6 0.0044 ** BP syst. [mmHG] 120.0 ± 4.5 108.3 ± 7.9 108.3 ± 1.3 0.2352 143.3 ± 13.7 110.0 ± 8.9 106.7 ± 2.6 0.0351 * BP diast. [mmHG] 83.3 ± 1.3 75.0 ± 3.9 73.3 ± 1.3 0.0321 * 85.0 ± 9.7 66.7 ± 2.6 70.0 ± 0.0 0.1002 Glucose [mg/dL] 102.0 ± 2.1 96.0 ± 0.8 88.3 ± 2.5 0.0010 *** 125.3 ± 10.4 94.3 ± 7.6 105.0 ± 3.8 0.0436 * HbA1C [%] 5.6 ± 0.1 5.3 ± 0.2 5.3 ± 0.0 0.2186 5.5 ± 0.1 5.3 ± 0.1 5.3 ± 0.2 0.5705 Triglycerides [mg/dL] 218.0 ± 30.9 113.7 ± 6.1 125.7 ± 9.1 0.0039 ** 169.3 ± 17.4 119.0 ± 7.5 117.0 ± 1.6 0.0086 ** Cholesterol [mg/dL] 224.7 ± 15.9 164.0 ± 2.4 176.3 ± 16.3 0.0165 * 206.0 ± 17.5 188.3 ± 16.1 218.7 ± 16.9 0.4640 HDL [mg/dL] 51.3 ± 2.7 42.3 ± 1.8 54.3 ± 2.9 0.0147 * 52.0 ± 3.9 44.7 ± 4.2 48.3 ± 4.3 0.4827 LDL [mg/dL] 143.3 ± 12.8 104.3 ± 4.5 108.7 ± 11.5 0.0383 * 133.0 ± 21.2 118.3 ± 21.4 143.0 ± 20.8 0.7147
* Within group comparison.